$8.740
-0.419 (-4.79%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による BBOT の予測・予想
Alphio's BBOT stock price prediction model matches the current BridgeBio Oncology Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.68 (-0.74%). The 1-week path is $8.83 (+1.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
BridgeBio Oncology Therapeutics Inc 株は買うべき？
Helix Acquisition Corp II (BBOT) is not a good buy right now due to its current price of $8.74, which is significantly below analyst price targets ranging from $22 to $29. The stock has a low RSI of 33.785, indicating it is oversold, but the negative catalysts such as a consistent decline in net income and a projected EPS of -0.71 suggest ongoing financial struggles. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.
BBOT の株価は Friday に $8.74 で引け、その前に下落 -4.79%
BridgeBio Oncology Therapeutics Inc (BBOT) last closed at $8.74, losing -4.79%. These facts feed the 1-day and 1-week BBOT price prediction above.
予想の要因
BridgeBio Oncology Therapeutics Inc（BBOT）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが BBOT に最も近い銘柄を、類似度順に表示します。
BBOT の季節性分析
Historically the probability of a positive August return for BBOT is 11.43%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。